drug

Estradiol/dyhydroprogestrone

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by The Alfred
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
NCT00206557Phase 2Completed

KOLs & investigators

1
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
The Alfred
company
trial
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
PHASE2
trial
indication
Schizophrenia
indication
Schizophreniform Disorder
indication
Mental Disorders
indication
Schizophrenia
indication
KOL
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHD
KOL score 5
person